Last reviewed · How we verify

Histalog (BETAZOLE)

FDA-approved approved Small molecule Quality 25/100

Histalog (BETAZOLE) is a small molecule betazole drug that targets the histamine H2 receptor. It is used for the stimulated gastric secretory test, but its commercial status is off-patent with no active Orange Book patents. Histalog works by blocking the histamine H2 receptor, which reduces gastric acid secretion. As an off-patent drug, it is not commercially available from generic manufacturers. Key safety considerations are not well-documented due to the lack of FDA approval and available information.

At a glance

Generic nameBETAZOLE
Drug classbetazole
TargetHistamine H2 receptor
ModalitySmall molecule
Therapeutic areaOther
PhaseFDA-approved
First approval1982

Approved indications

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: